Industry news
- Industry news
- Infection
News of the day
European Medicines Agency starts review of Pandemrix
August 27, 2010 --The European Medicines Agency has launched a review of Pandemrix on the request of the European Commission to investigate whether there is a link between cases of narcolepsy and vaccination with Pandemrix. A limited number of cases was reported, all collected through spontaneous reporting systems, mainly in Sweden and Finland. Pandemrix, an influenza vaccine, has been used since September 2009 for vaccination against H1N1 influenza in at least 30.8 million Europeans. moreAdvanced Life Sciences Sees Funding Opportunity for Restanza in New HHS Medical Countermeasure Report
CHICAGO, Aug 24, 2010 - Advanced Life Sciences Holdings, Inc. (OTC Bulletin Board: ADLS), a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, today announced plans to seek additional government funding for development of its novel, once-daily antibiotic, Restanza(TM) (cethromycin) based on a new, high-profile report from the Department of Health and Human Services... moreTwo-Thirds Respond to "Re-vaccination "
August 01, 2010 -- Study Highlights: 25 volunteers from previously conducted Phase 2a trial were "re-vaccinated" with the vaccine after 7 years as part of a Phase 2 trial. Two thirds of the study volunteers responded to re-vaccination with Vacc-4x, resulting in enhanced immune response to their HIV-virus. Vacc-4x was also found to trigger 'killer T-cells' that function to seek out and kill HIV-infected cells in the body, which is in line with the objective of a successful T-cell vaccine.... moreIndustry news search
Recent news
To keep up to date with news from this category use our 
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us